Irina Maric Selected Research

Chymotrypsin

1/2017

Enzymatic activities of circulating plasma proteasomes in newly diagnosed multiple myeloma patients treated with carfilzomib, lenalidomide and dexamethasone.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Irina Maric Research Topics

Disease

16	Neoplasms (Cancer) 01/2023 - 01/2010
12	Multiple Myeloma 10/2022 - 01/2011
11	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2021 - 01/2011
6	Eosinophilia 11/2023 - 01/2008
5	Systemic Mastocytosis 04/2024 - 01/2008
5	Smoldering Multiple Myeloma 11/2021 - 06/2014
5	Mastocytosis 12/2018 - 10/2009
4	Sickle Cell Anemia (Hemoglobin S Disease) 12/2015 - 08/2006
3	Hypereosinophilic Syndrome (Loeffler Endocarditis) 04/2024 - 01/2018
3	Fever (Fevers) 11/2023 - 11/2004
3	Residual Neoplasm 12/2021 - 01/2021
3	Disease Progression 01/2017 - 02/2015
3	Cytopenia 01/2016 - 06/2010
3	Leukemia 12/2013 - 02/2007
2	Cutaneous Mastocytosis 04/2024 - 01/2022
2	Angioedema 11/2023 - 03/2015
2	Fatigue 11/2023 - 11/2004
2	Mast Cell Activation Disorders (Mast-Cell Disease) 01/2023 - 01/2008
2	Endomyocardial Fibrosis 01/2023 - 11/2007
2	Hairy Cell Leukemia 12/2021 - 10/2020
2	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 01/2019 - 07/2018
2	Headache (Headaches) 01/2019 - 01/2016
2	Monoclonal Gammopathy of Undetermined Significance 01/2018 - 01/2016
2	Lymphoma (Lymphomas) 01/2017 - 06/2014
2	Autoimmune Diseases (Autoimmune Disease) 01/2017 - 02/2016
2	Lymphopenia (Lymphocytopenia) 02/2016 - 09/2011
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2016 - 08/2012
2	Fibrosis (Cirrhosis) 01/2016 - 08/2011
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 12/2013 - 01/2011
2	Hyperplasia 04/2012 - 12/2011
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 04/2012 - 11/2010
1	Cytokine Release Syndrome 12/2023
1	Myalgia 11/2023
1	Anaphylaxis (Anaphylactic Shock) 01/2021
1	Thrombocytopenia (Thrombopenia) 10/2020
1	Hemorrhage 10/2020
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2020
1	Infantile Epileptic-Dyskinetic Encephalopathy 01/2020
1	Opportunistic Infections (Opportunistic Infection) 01/2019
1	Immediate Hypersensitivity 01/2019
1	Hodgkin Disease (Hodgkin's Disease) 01/2019
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2018

Drug/Important Bio-Agent (IBA)

7	ibrutinibIBA 11/2020 - 02/2015
6	Chimeric Antigen ReceptorsIBA 01/2018 - 11/2010
4	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2017
4	Tryptases (Tryptase)IBA 01/2023 - 12/2015
4	carfilzomibIBA 11/2021 - 09/2015
4	Lenalidomide (CC 5013)FDA Link 11/2021 - 09/2015
3	Imatinib Mesylate (Gleevec)FDA Link 01/2023 - 11/2007
3	Dexamethasone (Maxidex)FDA LinkGeneric 11/2021 - 09/2015
3	Agammaglobulinaemia Tyrosine KinaseIBA 01/2020 - 04/2016
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2016
3	B-Cell Maturation AntigenIBA 01/2018 - 01/2016
3	Hydroxyurea (Hydrea)FDA LinkGeneric 11/2011 - 08/2006
2	Mechanistic Target of Rapamycin Complex 1IBA 10/2022 - 01/2022
2	Amino Acids FDA Link 10/2022 - 01/2022
2	Cladribine FDA LinkGeneric 12/2021 - 10/2020
2	Rituximab (Mabthera)FDA Link 12/2021 - 10/2020
2	purineIBA 12/2021 - 10/2020
2	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 01/2019 - 06/2015
2	Interleukin-5 (Interleukin 5)IBA 01/2019 - 11/2011
2	AntibodiesIBA 07/2018 - 02/2016
2	Proteasome InhibitorsIBA 01/2017 - 09/2015
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2017 - 09/2015
2	Interleukin-7 (Interleukin 7)IBA 02/2016 - 01/2010
2	Fetal Hemoglobin (Hemoglobin F)IBA 01/2016 - 12/2015
2	Immunoglobulins (Immunoglobulin)IBA 11/2015 - 01/2011
2	Immunoglobulin M (IgM)IBA 06/2014 - 02/2006
1	HLA-DR Antigens (HLA-DR)IBA 04/2024
1	mepolizumabIBA 11/2023
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2023
1	Protein Isoforms (Isoforms)IBA 01/2022
1	ofatumumab FDA Link 01/2021
1	Omalizumab (Xolair)FDA Link 01/2021
1	avelumabIBA 01/2021
1	serum P-component (CIt)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	fludarabineIBA 11/2020
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2020
1	AutoantibodiesIBA 01/2019
1	Sialic Acid Binding Immunoglobulin-like LectinsIBA 01/2019
1	Immunoglobulin E (IgE)IBA 01/2019
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2019
1	benralizumabIBA 01/2019
1	aerolysinIBA 07/2018
1	Chromogranin AIBA 03/2018
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2018
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2018
1	DexpramipexoleIBA 01/2018
1	SteroidsIBA 01/2018

Therapy/Procedure

24	Therapeutics 11/2023 - 08/2006
3	Drug Therapy (Chemotherapy) 04/2012 - 11/2010
2	Aftercare (After-Treatment) 04/2024 - 12/2013
2	Hematopoietic Stem Cell Transplantation 04/2016 - 12/2013
1	Heart Transplantation (Grafting, Heart) 01/2023
1	Radiotherapy 01/2021
1	Platelet Transfusion (Blood Platelet Transfusions) 10/2020
1	Cell Transplantation 01/2020
1	Subcutaneous Injections 01/2019